ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
4.000
-1.000 (-20.00%)
Jul 28, 2026, 9:32 AM EST
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $20.76 million as of July 28, 2026. Its market cap has decreased by -58.96% in one year.
Market Cap
20.76M
Enterprise Value
21.52M
Revenue
209.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.00
ChartMarket Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 20.76M, an increase of 760.14%. That is a compound annual growth rate of 9.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 20.76M | -39.43% |
| Dec 31, 2025 | 34.27M | -55.05% |
| Dec 31, 2024 | 76.25M | 3,046.50% |
| Dec 29, 2023 | 2.42M | -89.71% |
| Dec 30, 2022 | 23.55M | -12.89% |
| Dec 31, 2021 | 27.03M | -56.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 26.93M |
| EOM Pharmaceuticals Holdings | 26.41M |
| Provectus Biopharmaceuticals | 26.10M |
| BetterLife Pharma | 23.88M |
| Galera Therapeutics | 18.20M |
| Finch Therapeutics Group | 16.06M |
| Oncotelic Therapeutics | 15.96M |
| Inhibitor Therapeutics | 15.07M |